Exosite Licenses IoT Technology to West Pharmaceutical Services, Inc.

Exosite has licensed use of its IoT technology and solutions to West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration. West is using Exosite’s technology to support and accelerate its digital transformation initiatives, and the two organizations collaborated on a Digital Technology Center for West in Taiwan.

Exosite’s technologies have been validated in highly regulated markets similar to West’s and deployed across a variety of public and private cloud environments, helping companies like West provide new value to customers and stakeholders through digital monitoring and innovation.

“We are very pleased to see Exosite technologies deployed broadly across the healthcare marketplace,” said Hans Rempel, CEO, Exosite. “I’m confident that our mature technologies will contribute significantly to West’s digital transformation initiatives, and I look forward to the collaboration between our organizations in the coming years.”

Exosite continues to support West’s Digital Technology Center and other regional customers through its teams in both Taiwan and Minneapolis, as part of its zero-barrier IIoT applications, including ExoSense® and ExoHome®, and its off-the-shelf vertical solutions.

About West

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. West is headquartered in Exton, Pennsylvania, and supports its customers from locations across North and South America, Europe, Asia, and Australia.